Quantcast
Last updated on April 19, 2014 at 12:41 EDT

Latest NeuroMetrix Inc. Stories

2014-01-24 08:24:14

WALTHAM, Mass., Jan. 24, 2014 /PRNewswire/ -- From the moment people learn to walk, many are taught that exercise is the key to living a healthy life. Indeed, the long-term benefits of exercise are indisputable. However, for those with Type 2 diabetes, exercise isn't just a recreational activity or a way to ward off extra pounds. It's needed to ensure good health overall. Problem is, for the 25 percent of diabetes patients with painful diabetic neuropathy (PDN), the prospect of...

2014-01-08 08:29:46

WALTHAM, Mass., Jan. 8, 2014 /PRNewswire/ -- Living with diabetes can be tough any way one slices it. In addition to the challenges of managing one's diet and blood sugar levels, patients can experience shooting, stabbing or burning pains in their hands or feet unexpectedly and for no apparent reason. This condition is called painful diabetic neuropathy (PDN), and many with the condition are forced to deal with it on a daily basis. Imagine waking up in the middle of the night...

2013-12-10 12:32:55

WALTHAM, Mass., Dec. 10, 2013 /PRNewswire/ -- Is there anything more frustrating than waking up in the middle of a nice dream? Awakening in the middle of the night can negatively affect one's mood the next day. It's one thing to be roused by an alarm clock or persistent pet that wants to be fed or walked, but being jolted out of sleep by agonizing leg pain is another story. Unfortunately, many of those who suffer from a condition called Painful Diabetic Neuropathy (PDN) are all too...

2013-01-29 23:03:57

FirstVitals Health and Wellness Inc., of California, a technology-enabled service company focused on reducing complications of diabetes related to neuropathy and foot ulcers/amputation, announced that it has received a donation from NeuroMetrix, Inc. (Nasdaq:NURO) to supplement its Centers for Medicare and Medicaid Innovation (CMMI) Grant project in Hawaii. Honolulu, HI (PRWEB) January 29, 2013 NeuroMetrix, a medical device company focused on the diagnosis and treatment of the neurological...

2008-11-04 09:00:30

NeuroMetrix, Inc. (Nasdaq: NURO), a science-based medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control, announced today its financial results for the three- and nine-month periods ended September 30, 2008. Total revenues for the three months ended September 30, 2008,...

2008-10-08 09:00:51

NeuroMetrix, Inc. (Nasdaq: NURO), a science-based medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control, announced today that it has started shipping Needle Electromyography (EMG) modules for its ADVANCE NCS/EMG System. The ADVANCE EMG module interfaces seamlessly with...

2008-08-05 09:01:32

NeuroMetrix, Inc. (Nasdaq: NURO), a science-based medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control, announced today its financial results for the three- and six-month periods ended June 30, 2008. Total revenues for the three months ended June 30, 2008, the Company's...

2008-07-29 09:01:15

NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has completed the CE technical file for its ADVANCE System ("ADVANCE"). With this regulatory step, NeuroMetrix intends to begin marketing ADVANCE to neurologists, clinical neurophysiologists, hand surgeons, and other specialists in the EU. ADVANCE is a comprehensive platform for the performance of traditional nerve conduction studies and needle electromyography procedures. The technical specifications include a precision electrical...

2008-07-18 15:00:57

NeuroMetrix, Inc. (Nasdaq: NURO - News) today said it plans to issue its 2008 second quarter financial results before the opening of the market on Tuesday, August 5, 2008. The Company's management team will host a conference call and webcast at 10:00 A.M. Eastern time, on the same day, to discuss the Company's financial results for the Second quarter ended June 30, 2008 and to discuss business and financial developments and trends affecting the Company. The conference call may be...